This article is more than 5 years old. Information may no longer be current.
Allergan reports 3.2% drop in second-quarter total product net sales
Click Here to Manage Email Alerts
IRVINE, Calif. — Allergan reported a downturn in total product net sales for the second quarter compared with the second quarter of 2008, according to a press release from the company.
The company's total product net sales were $1.118 billion, or 3.2% lower than the second quarter 2008. Based on constant currency, total product net sales increased 2.2% over the second quarter a year ago.
Total specialty pharmaceutical net sales declined 0.6% compared with 2008. Based on constant currency, second-quarter total specialty pharmaceutical net sales rose 4.8%. Total medical device net sales fell 13.9%, or 8.5% based on constant currency, the release said.
Diluted earnings per share attributable to stockholders totaled $0.58, up from $0.47 reported during the second quarter 2008. Allergan's board of directors declared a second-quarter dividend of $0.05 per share, payable on Sept. 7 to stockholders on record as of Aug. 17.
For the third quarter, Allergan projects total product net sales of $1.05 billion to $1.10 billion. For fiscal year 2009, product net sales are expected to total $4.2 billion to $4.3 billion. Pharmaceutical net sales are projected to total $3.505 billion and $3.560 billion. Medical device net sales are expected to total $695 million to $740 million, according to the release.